UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000017472 |
|---|---|
| Receipt number | R000020151 |
| Scientific Title | Expression of galectin-9 and other biomarker cytokine in the immuno stimulated state |
| Date of disclosure of the study information | 2015/05/08 |
| Last modified on | 2016/05/09 17:28:52 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Expression of galectin-9 and other biomarker cytokine in the immuno stimulated state
Acronym
Expression of galectin-9 and other biomarker cytokine in the immuno stimulated state
Scientific Title
Expression of galectin-9 and other biomarker cytokine in the immuno stimulated state
Scientific Title:Acronym
Expression of galectin-9 and other biomarker cytokine in the immuno stimulated state
Region
| Japan |
Condition
Condition
Tuberculosis Latent tuberculosis
Classification by specialty
| Infectious disease |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
In latent tuberculosis and active tuberculosis patients, we identifies the Gal-9 and its receptor Tim3 expressing cells by multiple staining.with antibodies to various cell membrane antigen.
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
By studying the kinetics of galectin-9 as a biomarker, the immunoregulatory function of galectin-9 reveals.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 1 | years-old | <= |
Age-upper limit
| 75 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Letent tuberculosis 30, active tuberculosis 30 amd healthy volumteer who obteined a consent to this test
Key exclusion criteria
the person who dose not have enough judgment.
the person who is unconscious.
the person who need the attention for disease notification.
Target sample size
90
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Httroi Toshio |
Organization
Tohoku University
Division name
International Research Institute of Disaster Science
Zip code
Address
1-1 Seiryo-cho, Aoba-ku, Sendai
TEL
022-717-8220
toshatto@med.tohoku.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yugo Ashino |
Organization
Tohoku University
Division name
Division of Emerging Infectious Diseases, Graduate School of Medicine
Zip code
Address
1-1 Seiryo-cho, Aoba-ku, Sendai
TEL
022-717-8220
Homepage URL
ya82@rid.med.tohoku.ac.jp
Sponsor or person
Institute
Tohoku University
Institute
Department
Personal name
Funding Source
Organization
endowment
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 05 | Month | 08 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2013 | Year | 10 | Month | 28 | Day |
Date of IRB
Anticipated trial start date
| 2013 | Year | 10 | Month | 28 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
summarizing data
Management information
Registered date
| 2015 | Year | 05 | Month | 08 | Day |
Last modified on
| 2016 | Year | 05 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020151
